Tuesday, 10 November 2026
M
Meridian Globe
Live briefing
Listen to Monday Night Club— BBC Sport 足球Vietnam leader To Lam visits Japan as decades-old relationship evolves— 日经 Nikkei AsiaJapan headlight king Koito tears down Chinese rivals' lamps for bright ideas— 日经 Nikkei AsiaNetanyahu rival Eisenkot seeks 'wide' government, path to power uncertain— 日经 Nikkei AsiaSingapore Airlines unveils $1.6bn cabin revamp with giant double bed— 日经 Nikkei AsiaUkraine's Zaporizhzhia nuclear plant again relies on backup power— 日经 Nikkei AsiaMalaysia-Taiwan fraying ties threaten future chip investments— 日经 Nikkei AsiaIran war and ambiguous fuel pricing squeeze Indian fishermen— 日经 Nikkei AsiaListen to Monday Night Club— BBC Sport 足球Vietnam leader To Lam visits Japan as decades-old relationship evolves— 日经 Nikkei AsiaJapan headlight king Koito tears down Chinese rivals' lamps for bright ideas— 日经 Nikkei AsiaNetanyahu rival Eisenkot seeks 'wide' government, path to power uncertain— 日经 Nikkei AsiaSingapore Airlines unveils $1.6bn cabin revamp with giant double bed— 日经 Nikkei AsiaUkraine's Zaporizhzhia nuclear plant again relies on backup power— 日经 Nikkei AsiaMalaysia-Taiwan fraying ties threaten future chip investments— 日经 Nikkei AsiaIran war and ambiguous fuel pricing squeeze Indian fishermen— 日经 Nikkei Asia

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

Source MarketWatch 财经2h ago
Summary

Several medical studies have found that people taking GLP-1 medications have an elevated risk for nonarteritic anterior ischemic optic neuropathy, or NAION.

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Business
Region
Americas
Language
English
Item ID
business-97f02ba1

Comments 0 comments

No comments yet. Be the first.

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss · Meridian Globe